Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US10406172B2 · kind B2 · utility

11Cited by

72References

29Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Peter Eickelmann · Mittelbiberach, DE
Michael Mark · Biberach an der Riß, DE
Leo John SEMAN · Salem, US
Leo Thomas · Biberach, DE
Uli Christian BROEDL · Oakville, CA
Rolf GREMPLER · Mittelbiberach, DE

Key dates

Filing date	Jun 7, 2013
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Oct 9, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.